» Articles » PMID: 31934186

Primary Extramammary Paget's Disease: a Clinicopathological Study of 28 Cases

Overview
Specialty Pathology
Date 2020 Jan 15
PMID 31934186
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To analyze the clinical and histopathological manifestations, immunohistochemistry, treatment, and prognostic factors of primary, extramammary Paget's disease (EMPD), we systematically reviewed the clinical presentations, histopathology and follow-up courses of 28 patients with primary EMPD. Clinically, their symptoms and morphology mimicked various types of dermatoses, such as seborrheic dermatitis, eczema, candidiasis, tinea cruris and erythrasma, so the initial diagnosis of EMPD was often delayed or missed. Histopathology showed invasive EMPD, and the tumor cells were mostly solid nests or had a glandular structure. The cellular atypia was obvious and signet ring Paget's cells could usually be observed. The acantholysis phenomenon in the epidermis could be seen. The condition was associated with stromal invasion, lymphatic metastasis, and even vascular invasion. Adnexal involvement in primary EMPD was a very common feature. The immunohistochemical markers CK7, GCDFP-15, CEA and HER-2 positive can identify other tumors similar to Paget's disease. We concluded that invasive EMPD is a rare malignant skin neoplasm with morphological diversity. Poorly differentiated cell morphology, extensive adnexal involvement, and an invasive pattern of solid sheets are significantly associated with lymph node metastasis and a worse prognosis. Pathologists should be alert to invasive lesions and make the correct diagnosis.

Citing Articles

Clinicopathological Correlation and Recurrence Outcome of Adnexal Involvement on Primary Extramammary Paget's Disease (EMPD).

Aryal S, Bashyal S, Qiang L Cureus. 2024; 16(6):e61975.

PMID: 38855492 PMC: 11162301. DOI: 10.7759/cureus.61975.


Applications of photodynamic therapy in extramammary Paget's disease.

Ren F, Zhao S, Yang C, Liu J, Shang Q, Feng K Am J Cancer Res. 2023; 13(10):4492-4507.

PMID: 37970368 PMC: 10636668.


Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease.

Kang Z, Jiang L, Chen D, Yan G, Zhang G, Lai Y Skin Res Technol. 2023; 29(10):e13497.

PMID: 37881057 PMC: 10579628. DOI: 10.1111/srt.13497.


Cell origin and genome profile difference of penoscrotum invasive extramammary Paget disease compared with its counterpart.

Rao Y, Zhu J, Zheng H, Ren Y, Ji T Front Oncol. 2022; 12:972047.

PMID: 36091120 PMC: 9451029. DOI: 10.3389/fonc.2022.972047.


Vulvar Paget's Disease Presenting with Fever and Left Inguinal and Peritoneal Lymphadenopathies.

Hirata R, Tago M, Hisata Y, Yamashita S Am J Case Rep. 2021; 22:e931600.

PMID: 34462416 PMC: 8420681. DOI: 10.12659/AJCR.931600.


References
1.
Shiomi T, Noguchi T, Nakayama H, Yoshida Y, Yamamoto O, Hayashi N . Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth. J Eur Acad Dermatol Venereol. 2012; 27(5):589-92. DOI: 10.1111/j.1468-3083.2012.04489.x. View

2.
Shaco-Levy R, Bean S, Vollmer R, Papalas J, Bentley R, Selim M . Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course. Int J Gynecol Pathol. 2009; 29(1):69-78. DOI: 10.1097/PGP.0b013e3181b1cc5e. View

3.
Borghi C, Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V . Invasive Paget Disease of the Vulva. Int J Gynecol Cancer. 2017; 28(1):176-182. DOI: 10.1097/IGC.0000000000001131. View

4.
Onaiwu C, Ramirez P, Kamat A, Pagliaro L, Euscher E, Schmeler K . Invasive extramammary Paget's disease of the bladder diagnosed 18 years after noninvasive extramammary Paget's disease of the vulva. Gynecol Oncol Case Rep. 2014; 8:27-9. PMC: 4009448. DOI: 10.1016/j.gynor.2014.03.004. View

5.
Hanawa F, Inozume T, Harada K, Kawamura T, Shibagaki N, Shimada S . A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy. Case Rep Dermatol. 2011; 3(3):223-7. PMC: 3220911. DOI: 10.1159/000333002. View